[ad_1]
SANTA CLARA, California, 7. November 2018 / PRNewswire / – A team of Drs. The Rath Research Institute in California has developed a cancer vaccine
which reduces tumor growth. This peptide-based vaccine targets specific enzymes called metalloproteinases (MMPs), which are responsible for tumor growth.
The formation of metastases and blood vessels in tumors (angiogenesis) is responsible. Dr. Rath's research team has shown that the test mice vaccinated with peptides, the
MMP-2 and MMP-9 sequences, then infected with cancerous melanoma cells, result in an average tumor reduction of approximately 76% compared to unvaccinated cells
Animals in the control group. Remarkably, some vaccinated animals have not developed any cancer at all.
The study was published in October 2018 in the online Journal of Cell Medicine and Natural Health.
Source link
